Scientific Directory

Thèmes de recherche développés

Publications CSM

2022

• Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
  Pagnuzzi M, Picco V, Vial V, Planas-Bielsa V, Vandenberghe A, Daubon T, Derieppe M-A, Montemagno C, Durivault J, Grépin R, Martial S, Doyen J, Gavard J, Pagès G
  Cancers 14(1) : 70
• Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma
  Filipponi, D, Pagnuzzi M, Pagès G
  Cancers 14(9): 2095
• Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas
  Penco-Campillo M, Molina C, Piris P, Soufi N, Carré M, Pagnuzzi M, Picco V, , Dufies M, Ronco C, Benhida R, Martial S, Pagès G
  Cells 11(23), 3933

2021

• Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
  Dumond A, Brachet E, Durivault J, Vial V, Puszko A K, Lepelletier Y, Montemagno C, Pagnuzzi M, Hermine O, Garbay C, Lagarde N, Montes M, Demange L, Grépin R, Pagès G
  J Exp Clinical Cancer Research 40: 33

2020

• VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
  Penco-Campillo M, Comoglio Y, Feliz Morel A J, Hanna R, Durivault J, Leloire M, Mejias B, Pagnuzzi M, Morot A, Burel-Vandenbos F, Selby M, Williamson D, Clifford S C, Claren A, Doyen J, Picco V, Martial S, Pagès G
  Comm Biol 3(758): 579

2019

• Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
  Cormerais Y, Pagnuzzi M, Schrötter S, Giuliano S, Tambutté E, Endou H, Wempe M F, Pagès G, Pouyssegur J, Picco V
  J Cell Mol Med 1-8

2014

• The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma
  Grépin R, Guyot M, Giuliano S, Pagnuzzi M, Ambrosetti D, Chamorey E, Scoazec J Y, Negrier S, Simonnet H, Pagès G
  Cancer Res 74(3): 873-883